Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.
In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine.
The Chosun Ilbo on MSN
14.2 million COVID-19 vaccines with foreign substances administered
Foreign substances such as mold, hair, and silicon dioxide (silica) were found in COVID-19 vaccines, potentially introduced ...
NEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe ...
Union Health Minister J P Nadda launched the indigenously manufactured tetanus and adult diphtheria vaccine in Kasauli. The ...
Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.
US mRNA specialist Moderna today announced that the European Commission (EC) has granted marketing authorization for mNEXSPIKE (mRNA-1283), a new COVID vaccine, for active immunization to prevent ...
By Nate Raymond BOSTON, Feb 13 (Reuters) - Major U.S. medical groups urged a judge on Friday to block the Trump ...
In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.
Union Health Minister JP Nadda on Saturday launched the indigenously manufactured Tetanus and Adult Diphtheria (Td) vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results